SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-325057
Filing Date
2019-12-27
Accepted
2019-12-30 09:25:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d860208dsc13d.htm SC 13D 52119
  Complete submission text file 0001193125-19-325057.txt   53685
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Subject) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88225 | Film No.: 191315047
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 MONUMENT ROAD, SUITE 207 BALA CYNWYD PA 19004
Business Address 150 MONUMENT ROAD, SUITE 207 BALA CYNWYD PA 19004 844-511-9056
CHONDRIAL THERAPEUTICS HOLDINGS, LLC (Filed by) CIK: 0001776691 (see all company filings)

IRS No.: 814489294 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D